Oakstone Intensive Review of Nephrology 2025

Oakstone Intensive Review of Nephrology 2025

 Include: 94 videos + 2 pdfs, size: 26.2 GB

Target Audience: clinical and academic nephrologists, internists, pediatricians, and primary care physicians/trainees

 Information:

New Release! Unmatched Board Prep and Nephrology Update

The Intensive Review of Nephrology is an advanced online video course from School, designed to deliver an in-depth update across all areas of nephrology. Through 70+ expert-led lectures and case discussions, you’ll gain essential, evidence-based knowledge for optimizing diagnosis, treatment, and patient outcomes.

This continuing medical education program is ideal for clinicians seeking a comprehensive review and physicians preparing for ABIM certification or recertification. Expert faculty evidence-driven strategies for managing common and complex renal conditions. Highlights include:

• Genetic testing for improved diagnosis, prognosis and therapy selection
• Introduction to point-of-care ultrasound: fundamentals for optimal image acquisition and accurate interpretation
• Physical exam of the dialysis access
• Further expansion of the roles of SGLT2i and finerenone in diabetic and non-diabetic kidney disease
• New insights in immunology and the pathogenesis of glomerulonephritis
• Novel immunosuppressive agents for glomerulonephritis
• And more…

Date of Original Release: October 15, 2025
Estimated Time to Complete the Activity: 50.00 hours

Learning Objectives

Upon completion of this activity, participants will be able to:

• Summarize current/recommended nephrology guidelines in clinical practice
• Explain the differential diagnosis of complex clinical presentations of patients with renal disorders
• Identify/integrate current therapeutic options for specific renal disorders
• Review and interpret up-to-date literature relevant to clinical practice
• Describe pathophysiological mechanisms as they apply to management of renal disease
• Synthesize teachings to better performance on the ABIM Nephrology certification/recertification examinations

Target Audience

The target audience for the” Intensive Review of Nephrology” Course is clinical and academic nephrologists, internists, pediatricians, and primary care physicians/trainees preparing for ABIM nephrology certification/recertification examinations and/or seeking a comprehensive update in renal medicine and its subspecialties.

Topics:

• Renal Physiology for the Boards – Melanie P. Hoenig, MD
• Basic Concepts of Immunology in Autoimmune Kidney Disease – Ramon Bonegio, MD
• Question and Answer Session – Faculty
• Renal Pathology in 2025 – Part 1 – Nephritic Conditions – Helmut G. Rennke, MD
• Renal Pathology in 2025 – Part 2 – Nephritic Syndrome – Astrid Weins, MD, PhD
• Urine Sediment Analysis – Martina M. McGrath, MB BCh
• Question and Answer Session – Faculty
• Pathogenesis, Diagnosis, and Treatment of IgA Nephropathy – Gerald B. Appel, MD
• Metabolic Management of Kidney Stones – Gary Curhan, MD, ScD
• Keynote – AI in Nephrology – Girish N. Nadkarni, MD, MPH, CPH
• Question and Answer Session – Faculty
• Treating Lupus Nephritis in 2025 – New Guidelines, New Medications, and New Challenges – Gerald B. Appel, MD
• Membranous Nephropathy – Laurence H. Beck, Jr., MD, PhD
• Anemia Management – Update and Best Practices – Brona M. Moloney, MBBCH, BAO, MMSc
• Question and Answer Session – Faculty
• Acid-Base Disorders Part I – Anion Gap Metabolic Acidosis – Alan S.L. Yu, MB, BChir
• Acid-Base Disorders II – Non-Gap Acidosis and Metabolic Alkalosis – Alan S.L. Yu, MB, Bchir
• Question and Answer Session – Faculty
• Sodium Disorders – David B. Mount, MD
• Potassium Disorders – David B. Mount, MD
• Question and Answer Session – Faculty
• Important New Trials in GN – David B. Mount, MD
• Genetics and Kidney Disease – Friedhelm Hildebrandt, MD
• Update on Polycystic Kidney Disease – Fouad T. Chebib, MD, FASN
• Pediatric Nephrology – Michael J.G. Somers, MD
• Genetics – How to Integrate It into Practice – Ana Onuchic-Whitford, MD
• Diagnosis and Treatment of ANCA-associated Vasculitis – John L. Niles, MD
• Question and Answer Session – Faculty
• Why Do We Reject a Transplant? – Jamil R. Azzi, MD
• Transplant Immunosuppression for the Boards – Brittany L. Schreiber, MD
• Question and Answer Session – Faculty
• Immunological Assessment Pre and Post Transplant – Melissa Y. Yeung, MD and Indira Guleria, PhD
• Early Post-Transplant Management – Anil K. Chandraker, MD
• Question and Answer Session – Faculty
• Evaluation of the Living Donor Candidate – Kassem Safa, MD
• Late Loss of the Kidney Transplant – Rania Khedher El Fekih, MD
• Infections in Transplant Recipients – Barbra M. Blair, MD
• Monitoring Kidney Transplant Patients – Beyond Creatinine – Jamil R. Azzi, MD
• Pre-Transplant Surgical Evaluation of Recipients – Rania Khedher El Fekih, MD
• Question and Answer Session – Faculty
• Poisonings and Intoxications – What a Nephrologist Needs to Know – Charlotte E. Goldfine, MD
• Late Post-Transplant Medical Complications – Leonardo V. Riella, MD, PhD
• Hemolytic Uremic Syndrome (HUS) and Thrombotic Thrombocytopenic Purpura (TTP) – Jean M. Francis, MD
• Geriatric Nephrology – Ernest I. Mandel, MD
• Cardio-Renal Syndrome – Finnian R. McCausland, MB BCh, MMSc, FRCPI
• Management of Hypertension in CKD-Intensive or Standard Regimens – Richard J. Glassock, MD
• Question and Answer Session – Faculty
• Primary Aldosteronism – Anand Vaidya, MD, MMSc
• Keynote – Climate Change, Global Inequities, and the Kidney – Valerie A. Luyckx, MBBCh, MSc, PhD
• Liver and the Kidney – Andrew S. Allegretti, MD, MSc
• Question and Answer Session – Faculty
• Pathophysiology of Acute Kidney Injury – Joseph V. Bonventre, MD, PhD
• Acute Kidney Injury Syndromes – Alice Sheridan, MD
• ICU Nephrology and Continuous Renal Replacement Therapies – David J.R. Steele, MB BCh
• Question and Answer Session – Faculty
• Acute Kidney Injury in Cancer – Raad Chowdhury, MD
• Paraprotein-Induced Kidney Injury – Raad Chowdhury, MD
• Therapy of Focal and Segmental Glomerulosclerosis (FSGS) Lesions in 2025 – Richard J. Glassock, MD
• Pathophysiology and Treatment of Diabetic Kidney Disease – Gearoid M. McMahon, MB BCh
• APOL1 and Kidney Disease – Opeyemi Olabisi, MD, PhD
• Question and Answer Session – Faculty
• Patient Perspective – Dialysis Dosing – Moderators – J. Kevin Tucker, MD and Paul Moore; Dialysis Patients – Daphne Rhodes and Vanessa Evans
• Chronic Kidney Disease – Mineral and Bone Disease – David Bushinsky, MD
• Question and Answer Session – Faculty
• Dialysis – A Case-Based Clinical Review and Update – J. Kevin Tucker, MD
• Chronic Kidney Disease – Mineral and Bone Disease Case-Based Pearls – David Bushinsky, MD
• Chronic Kidney Disease Epidemiology – Gearoid M. McMahon, MB BCh
• Question and Answer Session – Faculty
• Introduction to Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC
• Complications of Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC
• Acute Kidney Injury Related to Immune Checkpoint Inhibitors – Shruti Gupta, MD
• Question and Answer Session – Faculty
• Mesoamerican Nephropathy – David J. Friedman, MD
• Ultrasound for the Clinical Nephrologist – Adina S. Voiculescu, MD
• Dialysis Vascular Access – Assessment and Complications – Dirk M. Hentschel, MD
• Question and Answer Session – Faculty
• Glomerulonephritis – Questions & Answers Session – Gerald B. Appel, MD
• Must-Know Clinical Images in Nephrology – Annie Liu, DO, MPH, MS
• Electrolytes and Acid-Base Practice for the Boards – Part 1 – Alan S.L. Yu, MB, Bchir
• Electrolytes and Acid-Base Practice for the Boards – Part 2 – Alan S.L. Yu, MB, Bchir
• Chronic Kidney Disease in the Community – Leveraging Resources Effectively, Lessons Learned from KDSAP – Li-Li Hsiao, MD, PhD, FACP
• COVID-19 Vaccination in Immunocompromised Patients – Ann Woolley, MD
• Update on Renovascular Disease – Joseph M. Garasic, MD
• Pre-Transplant Surgical Evaluation of Recipients – Sayeed Malek, MD
• Immunologic Basis of Kidney Disease – Vivek Kasinath, MD
• Use of Checkpoint Inhibitors in Kidney Transplant Recipients – Naoka Murakami, MD, PhD
• Interstitial Nephritis – Overview for the Boards – Julie M. Paik, MD, ScD, MPH
• Ethics in Nephrology – Valerie Luyckx, MD, MB BCh
• Pregnancy and Renal Disease – Jessica Tangren, MD
• Transplant Cases – Board Review Practice – Melissa Y. Yeung, MD and Edgar L. Milford, MD
• Transplant Board Review – Anil K. Chandraker, MD
• Must-Know Board Zebras – Emily Robinson, MD, MPH
• Nephrology Board Review Practice 1 – Finnian McCausland, MB BCh, MMSc, FRCPI
• Nephrology Board Review Practice 2 – Gearoid M. McMahon, MB BCh